News

The FDA is warning the public about a drug rising in popularity commonly referred to as as "gas station heroin." ...
The FDA is urging the food industry to phase out artificial food dyes, including Red Dye No. 3, citing potential health risks ...
"Most vaccines are not 100% effective, so you can see vaccine failures, but having vaccine failures doesn't mean the vaccine ...
The latest canine otitis externa medication is the only FDA-approved, one-dose, in-clinic treatment for Pseudomonas ...
The FDA has granted accelerated approval to avutometinib (VS-6766) plus defactinib (VS-6063) for the treatment of adult ...
Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...
Avutometinib given with defactinib is now approved for the treatment of adult patients with recurrent low-grade serous, ...
The FDA’s Oncologic Drugs Advisory Committee (ODAC) is planning to host its first meeting under new agency commissioner Marty ...
Dr. Eric Topol’s longevity work revealed simple and practical steps to stay healthy. He shares the tips that he follows.
The FDA has received reports of erectile dysfunction, anxiety, and more after using topical finasteride, a popular hair loss medication. Experts say the medication is still safe for many, but you ...
Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that Anthem Blue Cross and Blue Shield has approved its amblyopia treatment ...
Linda Tharby; President, Chief Executive Officer, Director; KORU Medical Systems Inc Tom Adams; Chief Financial Officer; KORU Medical Systems Inc Thank you, and good afternoon, everyone. Joining me on ...